These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3912366)

  • 1. Tissue levels in patients after intravenous administration of ceftazidime.
    Loebis LH
    J Antimicrob Chemother; 1985 Dec; 16(6):757-61. PubMed ID: 3912366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of ceftazidime into the human prostate gland following intravenous injection.
    Abbas AM; Taylor MC; Da Silva C; Francis RA; Bennet C
    J Antimicrob Chemother; 1985 Jan; 15(1):119-21. PubMed ID: 3882653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan.
    Saito A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():255-62. PubMed ID: 6352628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of ceftazidime into human tissue in patients undergoing cardiac surgery.
    Adam D; Reichart B; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():269-73. PubMed ID: 6352630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of ceftazidime into heart valves and subcutaneous and muscle tissue of patients undergoing open-heart surgery.
    Frank U; Kappstein I; Schmidt-Eisenlohr E; Schlosser V; Spillner G; Schindler M; Daschner FD
    Antimicrob Agents Chemother; 1987 May; 31(5):813-4. PubMed ID: 3300542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue.
    Daschner FD; Petersen EE; Just HM; Hillemanns HG
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():247-9. PubMed ID: 6352627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hemodialysis on ceftazidime pharmacokinetics.
    Nikolaidis P; Tourkantonis A
    Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime in the therapy of pseudomonal meningitis.
    Marone P; Concia E; Maserati R; Suter F; Minoli L; Andreoni M; Fiori G
    Chemioterapia; 1985 Aug; 4(4):289-92. PubMed ID: 3902257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary elimination of ceftazidime.
    Brogard JM; Jehl F; Pâris-Bockel D; Blicklé JF; Adloff M; Monteil H
    J Antimicrob Chemother; 1987 May; 19(5):671-8. PubMed ID: 3301782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
    Tourkantonis A; Nicolaidis P
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():263-7. PubMed ID: 6352629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of ceftazidime into bronchial secretions in critically ill patients.
    Langer M; Cantoni P; Bellosta C; Boccazzi A
    J Antimicrob Chemother; 1991 Dec; 28(6):925-32. PubMed ID: 1816189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental and clinical evaluations of ceftazidime in neonates].
    Nakazawa S; Sato H; Hirama Y; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Chikaoka H; Tazoe K; Koido R
    Jpn J Antibiot; 1986 Aug; 39(8):2108-19. PubMed ID: 3540344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of ceftazidime injected peritoneally in continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Vergnaud M; Hurault de Ligny B; Allouche G; Malbruny B; Morel C
    Pathol Biol (Paris); 1986 May; 34(5):328-31. PubMed ID: 3534700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime: experimental and clinical evaluation of biliary elimination.
    Brogard JM; Jehl F; Monteil H; Blickle JF; Arnaud JP
    Drugs Exp Clin Res; 1987; 13(2):105-14. PubMed ID: 3556121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats.
    Miglioli PA; Xerri L; Palatini P
    Pharmacology; 1991; 43(5):242-6. PubMed ID: 1784624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
    Albarellos GA; Ambros LA; Landoni MF
    Vet J; 2008 Nov; 178(2):238-43. PubMed ID: 17768077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum and cerebrospinal fluid kinetics of ceftazidime].
    Nadstawek J; Weil HP; Frenkel C; Kühnen E; Mauersberger W; Hörnchen U
    Immun Infekt; 1989 Dec; 17(6):212-6. PubMed ID: 2693344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical evaluation of ceftazidime in neonates and premature infants].
    Sato Y; Iwata S; Kusumoto Y; Shiro H; Oikawa T; Osano M
    Jpn J Antibiot; 1986 Aug; 39(8):2084-96. PubMed ID: 3540342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.